Jim Cramer Reports That Eli Lilly and Company (LLY)'s Donanemab Was Approved in Japan For Treating Early Symptomatic Alzheimer's Disease

By Yahoo! Finance | Sep 28, 2024 at 10:14 AM EST

Jim Cramer shared early investment experiences and the importance of starting young in the stock market. Eli Lilly & Company (LLY) stands out for its strong financial performance and innovative drug lineup, making it a promising investment choice.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.